4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001415889-25-000405
PRESIDENT AND CEO acquired 44,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Russo Rene PRESIDENT AND CEO | 2025-01-01 | Option exercise | +44,250 | 244,883 | D | ||
| Derivatives | |||||||
| Russo Rene PRESIDENT AND CEO | 2025-01-01 | Option exercise · Restricted Stock Units | −44,250 | 132,750 | D | ||
| Russo Rene PRESIDENT AND CEO | 2025-01-01 | Grant or award · Stock Option (right to buy) | +638,000 | 638,000 | D | ||
Loading xslF345X05/form4-01032025_040111.xml…